+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Chronic Rhinosinusitis With Nasal Polyps - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Rhinosinusitis With Nasal Polyps - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Spinal Cord Injury- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spinal Cord Injury- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adrenoleukodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Adrenoleukodystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Autoimmune Hepatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Autoimmune Hepatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Autosomal Dominant Polycystic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Autosomal Dominant Polycystic Kidney Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Achondroplasia - Pipeline Insight, 2025 - Product Thumbnail Image

Achondroplasia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chemotherapy Induced Febrile Neutropenia - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Febrile Neutropenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Chemotherapy Induced Neutropenia - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Neutropenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chemotherapy-induced Thrombocytopenia (CIT) - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy-induced Thrombocytopenia (CIT) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cholestatic Pruritus- Pipeline Insight, 2025 - Product Thumbnail Image

Cholestatic Pruritus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Choroideremia - Pipeline Insight, 2025 - Product Thumbnail Image

Choroideremia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Heart Failure- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Heart Failure- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chronic Idiopathic Constipation (CIC) - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Idiopathic Constipation (CIC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Idiopathic Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Idiopathic Urticaria- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chronic Liver Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Liver Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Lower Back Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Lower Back Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Chronic Obstructive Lung Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Obstructive Lung Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Relapsed/Refractory Epstein Barr Virus - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed/Refractory Epstein Barr Virus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Respiratory Syncytial Virus (RSV)- Pipeline Insight, 2025 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more